A first-in-human dose escalation and dose-finding phase I/II trial of IMAB027 in patients with recurrent advanced ovarian cancer (GM-IMAB-002-01).
Journal Article published 20 May 2014 in Journal of Clinical Oncology volume 32 issue 15_suppl on pages TPS5623 to TPS5623
Authors: Dirk Jaeger, Ugur Sahin, Oezlem Tureci
Multicenter Phase 2 Trial of C is/Carboplatin, nAb -Paclitaxel, and C e TUX imab ( CACTUX ) as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Journal Article published Apr 2018 in International Journal of Radiation Oncology*Biology*Physics volume 100 issue 5 on pages 1311 to 1312
Authors: D. Adkins, J. Ley, O. Atiq, C. Rigden, K. Trinkaus, T.M. Wildes, P. Oppelt